A Trial of SHR0410 Injection in Hemodialysis Participants.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

November 8, 2019

Study Completion Date

November 8, 2019

Conditions

Pruritus

Interventions

DRUG

SHR0410

drug will be dosed repeatedly

DRUG

Placebo

Placebo will be dosed repeatedly

Trial Locations (1)

Linear Clinical Research, Nedlands

All Listed Sponsors

lead

Atridia Pty Ltd.

INDUSTRY

NCT03857568 - A Trial of SHR0410 Injection in Hemodialysis Participants. | Biotech Hunter | Biotech Hunter